Primaquine Tablets

Designed to support malaria clearance to manage relapsing plasmodium strains and alleviate systemic illness.

Dosage

Pack size

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Primaquine Tablets vary by destination and are determined by the fulfilment partner.

Primaquine Tablets details

Condition: Malaria Radical Cure
Alternative names: primaquine phosphate
Therapeutic class: 8-Aminoquinoline
Pharmacological class: Antimalarial Agent
Known off-label uses: pneumocystis pneumonia treatment
Minor side effects: nausea; vomiting; abdominal cramps
Moderate side effects: headache; haemolysis in mild G6PD deficiency; methaemoglobinaemia
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Onset Time: 1–2 days
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Quinidines; G6PD-testing before use required
Age restrictions: Approved for paediatric and adult populations.

Contraindications

glucose-6-phosphate dehydrogenase (G6PD) deficiency; pregnancy; acutely ill patients

Serious side effects

severe haemolytic anaemia, requires immediate medical attention; acute bone marrow depression, requires immediate medical attention

Patient summary

designed to support malaria clearance to manage relapsing plasmodium strains and alleviate systemic illness.

Mechanism of action

Disrupts the mitochondrial function of liver-stage malaria parasites, preventing recurrent blood infection.

Pregnancy and breastfeeding

TGA Category X: Highly contraindicated. Fetal hazard. Breastfeeding: Avoid unless infant is G6PD normal.

Primaquine Tablets is a generic medicine sold under the name of its active ingredient, Primaquine, rather than under a brand.

The fulfilment partner confirms the offered manufacturer and product before supply.
Check the active ingredient, strength, form and pack shown at checkout before confirming an order.